Previous close | 459.70 |
Open | 472.80 |
Bid | 459.75 x 0 |
Ask | 461.75 x 0 |
Day's range | 460.85 - 472.95 |
52-week range | 398.50 - 517.00 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 16 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
By selling these assets, UnitedHealth (UNH) and Amedisys aim to avoid potential monopoly issues and ensure a smoother merger process.
Insightful Portfolio Adjustments Reflect a Focused Investment Strategy
Walgreens CEO Tim Wentworth is reversing his predecessors' course to focus more on retail pharmacy needs in communities compared to a more vertically integrated healthcare strategy.